Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy Induced Anemia”

66 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 66 results

Post-approval studies (Phase 4)Study completedNCT00315484
What this trial is testing

Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia

Who this might be right for
AnemiaChemotherapy
Ortho Biotech Products, L.P. 358
Large-scale testing (Phase 3)Study completedNCT00003600
What this trial is testing

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Who this might be right for
AnemiaBreast CancerChronic Myeloproliferative Disorders+8 more
Alliance for Clinical Trials in Oncology 344
Not applicableStudy completedNCT01807091
What this trial is testing

Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Who this might be right for
Adult Acute Myeloid LeukemiaAdult Myelodysplastic Syndrome
University of Washington 17
Large-scale testing (Phase 3)UnknownNCT05704894
What this trial is testing

Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens

Who this might be right for
AnemiaNeoplasmsChemotherapeutic-Induced Anemia
Blau Farmaceutica S.A. 320
Large-scale testing (Phase 3)Study completedNCT00110955
What this trial is testing

Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy

Who this might be right for
AnemiaNon-Myeloid Malignancies
Amgen 391
Large-scale testing (Phase 3)UnknownNCT00482716
What this trial is testing

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+2 more
St. Bartholomew's Hospital 80
Testing effectiveness (Phase 2)WithdrawnNCT00481624
What this trial is testing

Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia

Who this might be right for
Anemia
University of Louisville
Testing effectiveness (Phase 2)Study completedNCT00239239
What this trial is testing

Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies

Who this might be right for
Non-Myeloid MalignanciesAnemiaCancer
Amgen 44
Testing effectiveness (Phase 2)UnknownNCT02145923
What this trial is testing

Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

Who this might be right for
Neutropenic EnterocolitisMyeloablative Chemotherapy Induced Bone Marrow Aplasia
Burnasyan Federal Medical Biophysical Center 16
Large-scale testing (Phase 3)Study completedNCT00144495
What this trial is testing

Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Who this might be right for
Chemotherapy Induced Anemia
Chugai Pharmaceutical 104
Testing effectiveness (Phase 2)Ended earlyNCT00210002
What this trial is testing

Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced

Who this might be right for
NeoplasmsAnemia
Institut Claudius Regaud 55
Testing effectiveness (Phase 2)UnknownNCT02781155
What this trial is testing

Limiting Chemotherapy Side Effects by Using Moxa

Who this might be right for
Breast NeoplasmsColorectal NeoplasmsGenital Neoplasms, Female+1 more
East and North Hertfordshire NHS Trust 25
Large-scale testing (Phase 3)Study completedNCT01145638
What this trial is testing

Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoiesis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA)

Who this might be right for
Non-myeloid MalignanciesChemotherapy Induced Anaemia
Pharmacosmos A/S 350
Large-scale testing (Phase 3)Study completedNCT00144482
What this trial is testing

Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Who this might be right for
Chemotherapy Induced Anemia
Chugai Pharmaceutical 122
Not applicableStudy completedNCT00212862
What this trial is testing

Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia

Who this might be right for
AnemiaCancer
Ortho Biotech Products, L.P. 2,130
Testing effectiveness (Phase 2)Study completedNCT01297543
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+1 more
Cellerant Therapeutics 45
Large-scale testing (Phase 3)Ended earlyNCT04607668
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):

Who this might be right for
Colorectal Cancer MetastaticMyelosuppression-AdultChemotherapeutic Toxicity
G1 Therapeutics, Inc. 326
Testing effectiveness (Phase 2)Study completedNCT00272662
What this trial is testing

Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy

Who this might be right for
Chemotherapy Induced AnemiaCancer
Affymax 60
Post-approval studies (Phase 4)Study completedNCT01374373
What this trial is testing

Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia

Who this might be right for
Antineoplastic Chemotherapy Induced Anemia
Bio Sidus SA 30
Testing effectiveness (Phase 2)Study completedNCT00338299
What this trial is testing

Alternate Dosing of PROCRIT (Epoetin Alfa) in Patients With Cancer and Chemotherapy Induced Anemia

Who this might be right for
AnemiaChemotherapy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 51
Load More Results